These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9524796)

  • 21. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
    Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography.
    Chase TN; Foster NL; Fedio P; Brooks R; Mansi L; Di Chiro G
    Ann Neurol; 1984; 15 Suppl():S170-4. PubMed ID: 6611118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula.
    Nestor PJ; Graham NL; Fryer TD; Williams GB; Patterson K; Hodges JR
    Brain; 2003 Nov; 126(Pt 11):2406-18. PubMed ID: 12902311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Change of cerebral metabolism rate of glucose of cerebral white matter in Alzheimer's disease: a study with statistical parametric mapping software].
    Cao QY; Guo WH; Yang HL; Shen DW; Zhao P; Jiang KD; Zhang MY; Xiao SF
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2777-9. PubMed ID: 18167271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.
    Hunt A; Schönknecht P; Henze M; Seidl U; Haberkorn U; Schröder J
    Psychiatry Res; 2007 Jul; 155(2):147-54. PubMed ID: 17524628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications.
    Smith GS; de Leon MJ; George AE; Kluger A; Volkow ND; McRae T; Golomb J; Ferris SH; Reisberg B; Ciaravino J
    Arch Neurol; 1992 Nov; 49(11):1142-50. PubMed ID: 1444881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's disease: focal cortical changes shown by positron emission tomography.
    Foster NL; Chase TN; Fedio P; Patronas NJ; Brooks RA; Di Chiro G
    Neurology; 1983 Aug; 33(8):961-5. PubMed ID: 6603596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporoparietal cortex in aphasia. Evidence from positron emission tomography.
    Metter EJ; Hanson WR; Jackson CA; Kempler D; van Lancker D; Mazziotta JC; Phelps ME
    Arch Neurol; 1990 Nov; 47(11):1235-8. PubMed ID: 2241621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose metabolism and rate constants in Alzheimer's disease examined with dynamic positron emission tomography scan.
    Fukuyama H; Kameyama M; Harada K; Nishizawa S; Senda M; Mukai T; Yonekura Y; Torizuka K
    Acta Neurol Scand; 1989 Oct; 80(4):307-13. PubMed ID: 2816287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal studies of regional cerebral metabolism in Alzheimer's disease.
    Jagust WJ; Friedland RP; Budinger TF; Koss E; Ober B
    Neurology; 1988 Jun; 38(6):909-12. PubMed ID: 3259296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
    Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
    J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender differences in cortical glucose metabolism in Alzheimer's disease and normal aging.
    Siegel BV; Shihabuddin L; Buchsbaum MS; Starr A; Haier RJ; Valladares Neto DC
    J Neuropsychiatry Clin Neurosci; 1996; 8(2):211-4. PubMed ID: 9081560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of regional cerebral glucose utilization with delusions in Alzheimer's disease.
    Hirono N; Mori E; Ishii K; Kitagaki H; Sasaki M; Ikejiri Y; Imamura T; Shimomura T; Ikeda M; Yamashita H
    J Neuropsychiatry Clin Neurosci; 1998; 10(4):433-9. PubMed ID: 9813789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional metabolism: associations with dyscalculia in Alzheimer's disease.
    Hirono N; Mori E; Ishii K; Imamura T; Shimomura T; Tanimukai S; Kazui H; Hashimoto M; Yamashita H; Sasaki M
    J Neurol Neurosurg Psychiatry; 1998 Dec; 65(6):913-6. PubMed ID: 9854970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease.
    Sakamoto S; Ishii K; Sasaki M; Hosaka K; Mori T; Matsui M; Hirono N; Mori E
    J Neurol Sci; 2002 Aug; 200(1-2):27-32. PubMed ID: 12127672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuronal substrates for semantic memory: a positron emission tomography study in Alzheimer's disease.
    Hirono N; Mori E; Ishii K; Imamura T; Tanimukai S; Kazui H; Hashimoto M; Takatsuki Y; Kitagaki H; Sasaki M
    Dement Geriatr Cogn Disord; 2001; 12(1):15-21. PubMed ID: 11125237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Working memory and language network dysfunctions in logopenic aphasia: a task-free fMRI comparison with Alzheimer's dementia.
    Whitwell JL; Jones DT; Duffy JR; Strand EA; Machulda MM; Przybelski SA; Vemuri P; Gregg BE; Gunter JL; Senjem ML; Petersen RC; Jack CR; Josephs KA
    Neurobiol Aging; 2015 Mar; 36(3):1245-52. PubMed ID: 25592958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined study of cerebral glucose metabolism and [11C]methionine accumulation in probable Alzheimer's disease using positron emission tomography.
    Salmon E; Gregoire MC; Delfiore G; Lemaire C; Degueldre C; Franck G; Comar D
    J Cereb Blood Flow Metab; 1996 May; 16(3):399-408. PubMed ID: 8621744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral mapping of apraxia in Alzheimer's disease by positron emission tomography.
    Foster NL; Chase TN; Patronas NJ; Gillespie MM; Fedio P
    Ann Neurol; 1986 Feb; 19(2):139-43. PubMed ID: 3485952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.